NASDAQ
Capricor Therapeutics, Inc. (CAPR) has a fcf yield of -5.42% as of Monday, August 3, 2026. This represents a 60.31% increase compared to its 12-month average of -13.66%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.